KR

Koilada Rupadevi

Active Director Designated Partner DIN 10582779
DIN 10582779 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Koilada Rupadevi

Data last updated:

Koilada Rupadevi is a Designated Partner at Trigin Life Sciences Llp (since 2024). The company operates in Pharma.

DIN 10582779
Primary Designation Designated Partner
Industry Pharma
First Appointment 07 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner07 Apr 20242024Active

Board colleagues of Koilada Rupadevi

NameDINCompanyDesignation
Surya Kantham Gourisetti10582778Trigin Life Sciences LlpDesignated Partner
Venkateswaramma Eatur10582777Trigin Life Sciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Trigin Life Sciences Llp
Premium access

Shareholding and investment profile for Koilada Rupadevi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Koilada Rupadevi

Koilada Rupadevi currently holds 1 directorship: Trigin Life Sciences Llp (Designated Partner, since 07 Apr 2024).

Koilada Rupadevi was first appointed on 07 Apr 2024 as Designated Partner at Trigin Life Sciences Llp.

The current boards of Koilada Rupadevi's companies include Surya Kantham Gourisetti (Trigin Life Sciences Llp), Venkateswaramma Eatur (Trigin Life Sciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available